Stock Details
ABT is Abbott Laboratories's stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 112.91$. Average daily volumn in 3 months 5.51M. Market cap 191.64B



Stock symbol : ABT. Exchange : NYSE. Currency : USD
Lastest price : 109.45$. Total volume : 14.30M. Market state CLOSED
Click reload if you want to check the lastest price on market!!!

Abbott Laboratories (ABT)
Last Price
109.45$
Change
3.24
Volume
14.30M

Previous Close106.21
Open107.00
Day Range106.44-109.62
Bid108.80 x 800
Ask109.60 x 1.2k
Volume14.3M
Average Volume5.51M
Market Cap191.64B
Beta0.72
52 Week Range101.24-142.60
Trailing P/E25.41
Foward P/E22.38
Dividend (Yield %)1.83%
Ex-Dividend Date2022-07-14



Financial Details


According to Abbott Laboratories's financial reports the company's revenue in 2021 were 43.08B an increase( +26.47%) over the years 2020 revenue that were of 34.61B. In 2021 the company's total earnings were 7.07B while total earnings in 2020 were 4.5B( +75%).


Loading ...



Organization

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecologi... cal disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Mรฉniรจre's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Market Cap:
191.64B
Revenue:
43.08B
Total Assets:
75.2B
Total Cash:
9.8B



News about "Abbott Laboratories"

abbott-laboratories-nyseabt-price-target-cut-to-13000-by-analysts-at-btig-research-image

Abbott Laboratories (NYSE:ABT) Price Target Cut to $130.00 by Analysts at BTIG Research

Source from : Defense World - 11 hours ago

Abbott Laboratories (NYSE:ABT โ€“ Get Rating) had its target price decreased by BTIG Research from $140.00 to $130.00 in a research note published on Friday, The Fly reports. BTIG Research currently has ...See details»


what-6-analyst-ratings-have-to-say-about-abbott-laboratories-image

What 6 Analyst Ratings Have To Say About Abbott Laboratories

Source from : Business Insider - 1 days ago

Abbott Laboratories (NYSE:ABT) has observed the following analyst ratings within the last quarter: In the last 3 months, 6 analysts have offered 12-month price targets for Abbott Laboratories. The ...See details»


capital-investment-advisors-llc-sells-139-shares-of-abbott-laboratories-nyseabt-image

Capital Investment Advisors LLC Sells 139 Shares of Abbott Laboratories (NYSE:ABT)

Source from : Defense World - 9 hours ago

Capital Investment Advisors LLC decreased its position in shares of Abbott Laboratories (NYSE:ABT โ€“ Get Rating) by 1.0% in the 1st quarter, Holdings Channel reports. The fund owned 13,196 shares of ...See details»


has-abbott-labs-declined-to-an-attractive-level-image

Has Abbott Labs Declined to an Attractive Level?

Source from : TheStreet.com - 1 days ago

Abbott Laboratories ( ABT) has been under selling pressure from late December before the shut down and negative publicity surrounding the baby formula shortage. Has the decline from late December to ...See details»


absurd-loophole-cant-keep-abbott-formula-lawsuits-in-federal-court-judge-image

'Absurd' loophole can't keep Abbott formula lawsuits in federal court -judge

Source from : Reuters - 2 days ago

Abbott Laboratories Inc cannot use a controversial legal loophole known as "snap removal" to keep lawsuits claiming that its Similac baby formula caused a deadly illness in premature infants in ...See details»


The death of another baby linked to Abbott infant formula apparently under investigation

Source from : Food Safety News - 16 hours ago

According to press reports, the Food and Drug Administration said on Wednesday it was notified of one more infant death in January potentially related to Abbott Laboratoriesโ€™ baby formula and the ...See details»


Here's How Much $1000 Invested In Abbott Laboratories 5 Years Ago Would Be Worth Today

Source from : Benzinga.com - 1 days ago

Abbott Laboratories (NYSE:ABT) has outperformed the market over the past 5 years by 7.3% on an annualized basis producing an average annual return of 17.14%. Currently, Abbott Laboratories has a ...See details»


fda-investigates-new-report-of-another-babys-death-possibly-tied-to-abbott-formula-image

FDA investigates new report of another babyโ€™s death possibly tied to Abbott formula

Source from : WJBK - 2 days ago

The FDA has reviewed dozens of complaints involving Abbott formula after the company voluntarily recalled its products in February.See details»


fda-investigating-a-tenth-infant-who-died-after-consuming-abbott-labs-baby-formula-product-image

FDA investigating a tenth infant who died after consuming Abbott Labs baby formula product

Source from : World Socialist Web Site - 1 days ago

The FDA reported Wednesday that the baby died in January, a consumer complaint was filed in February but the agency only became aware of the complaint on June 10.See details»


fda-investigating-another-baby-death-possibly-tied-to-abbott-formula-image

FDA investigating another baby death possibly tied to Abbott formula

Source from : New York Post - 2 days ago

The baby died in January and had โ€œconsumed an Abbott product,โ€ the Food and Drug Administration said Wednesday, citing a consumer complaint sent to the agency in February.See details»


fda-investigating-death-of-another-infant-fed-abbott-baby-formula-image

FDA investigating death of another infant fed Abbott baby formula

Source from : Washington Examiner on MSN.com - 2 days ago

The Food and Drug Administration is investigating another infant's death following consumption of Abbott Laboratories baby formula.See details»


fda-investigates-death-of-another-infant-given-abbott-formula-image

FDA investigates death of another infant given Abbott formula

Source from : Detroit News - 2 days ago

U.S. Food and Drug Administration officials are investigating the death of another infant who was given formula made by Abbott Laboratories. The infant died in January and the FDA was notified June 10 ...See details»


Why Investors Should Focus on Abbott's Medical Devices

Source from : Nasdaq - 2 days ago

Given the headlines surrounding the infant formula debacle and the influx of cash from COVID-19 diagnostics, it's easy to overlook the company's innovation in medical devices. But this segment ...See details»


us-fda-gets-complaint-of-one-more-infant-death-related-to-baby-formula-image

U.S. FDA gets complaint of one more infant death related to baby formula

Source from : Reuters - 3 days ago

The U.S. Food and Drug Administration said on Wednesday it was notified of one more infant death in January potentially related to Abbott Laboratories' baby formula and the agency has started a probe.See details»